Literature DB >> 3319664

Neurotensin and cholecystokinin coexistence within neurons of the ventral mesencephalon: projections to forebrain.

K B Seroogy1, A Mehta, J H Fallon.   

Abstract

The colocalization of neurotensin- and cholecystokinin-like immunoreactivities was demonstrated in neurons of the ventral mesencephalon of the rat by using a double-labeling indirect immunofluorescence procedure for the simultaneous detection of two antigens in the same tissue section. Greater than 90% of the neurotensin-positive perikarya distributed throughout the ventral midbrain (primarily located in the ventral tegmental area, medial substantial nigra, and rostral and caudal linear raphe nuclei) were found to also contain cholecystokinin immunoreactivity. Neurons single-labeled for either peptide were also present, with those immunoreactive for cholecystokinin alone far outnumbering those containing only neurotensin. By combining the double-labeling colocalization technique with fluorescence retrograde tracing, some of the forebrain projections of these neurons were determined. Ventral mesencephalic neurons containing both neurotensin and cholecystokinin were found to project to the nucleus accumbens, prefrontal cortex, or amygdala. The present results, combined with those of previous studies, suggest that there are complex heterogeneous subpopulations of presumed dopaminergic ventral mesencephalic neurons which give rise to the ascending mesotelencephalic systems and which may contain both neurotensin and cholecystokinin, either peptide alone, or neither of these two peptides.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319664     DOI: 10.1007/BF00248793

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  52 in total

1.  Fluorescent antibody methods.

Authors:  A H COONS
Journal:  Gen Cytochem Methods       Date:  1958

Review 2.  Cholecystokinin and schizophrenia.

Authors:  N P Nair; S Lal; D M Bloom
Journal:  Prog Brain Res       Date:  1986       Impact factor: 2.453

3.  Peptide-monoamine coexistence: studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons.

Authors:  L R Skirboll; A A Grace; D W Hommer; J Rehfeld; M Goldstein; T Hökfelt; B S Bunney
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

4.  The effects of chronic neuroleptic treatment on neurotensin-like immunoreactivity in the rat central nervous system.

Authors:  M Goedert; S D Iversen; P C Emson
Journal:  Brain Res       Date:  1985-06-03       Impact factor: 3.252

5.  A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing.

Authors:  T Hökfelt; L Skirboll; J F Rehfeld; M Goldstein; K Markey; O Dann
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

6.  Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.

Authors:  G Zetler
Journal:  Eur J Pharmacol       Date:  1983-10-28       Impact factor: 4.432

7.  Coexistence of neuropeptides in projection neurons of the thalamus in the cat.

Authors:  T Sugimoto; K Itoh; Y Yasui; T Kaneko; N Mizuno
Journal:  Brain Res       Date:  1985-11-18       Impact factor: 3.252

8.  Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse.

Authors:  G Zetler
Journal:  Neuropharmacology       Date:  1982-08       Impact factor: 5.250

9.  Neurotensin-induced hypothermia: evidence for an interaction with dopaminergic systems and the hypothalamic--pituitary--thyroid axis.

Authors:  C B Nemeroff; G Bissette; P J Manberg; A J Osbahr; G R Breese; A J Prange
Journal:  Brain Res       Date:  1980-08-11       Impact factor: 3.252

10.  CCK-8 modulation of mesolimbic dopamine: antagonism of amphetamine-stimulated behaviors.

Authors:  L H Schneider; J E Alpert; S D Iversen
Journal:  Peptides       Date:  1983 Sep-Oct       Impact factor: 3.750

View more
  14 in total

Review 1.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

2.  Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.

Authors:  Pat Bauco; Pierre-Paul Rompré
Journal:  Psychopharmacology (Berl)       Date:  2003-04-08       Impact factor: 4.530

3.  Further analysis of presence of peptides in dopamine neurons. Cholecystokinin, peptide histidine-isoleucine/vasoactive intestinal polypeptide and substance P in rat supramammillary region and mesencephalon.

Authors:  K Seroogy; Y Tsuruo; T Hökfelt; J Walsh; J Fahrenkrug; P C Emson; M Goldstein
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

Review 4.  Role of central neurotensin in regulating feeding: Implications for the development and treatment of body weight disorders.

Authors:  Laura E Schroeder; Gina M Leinninger
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-12-27       Impact factor: 5.187

5.  Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry.

Authors:  K Seroogy; M Schalling; S Brené; A Dagerlind; S Y Chai; T Hökfelt; H Persson; M Brownstein; R Huan; J Dixon
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

6.  Presence of somatostatin or neurotensin in lateral septal dopaminergic axon terminals of distinct hypothalamic and midbrain origins: convergence on the somatospiny neurons.

Authors:  R L Jakab; C Leranth
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

7.  Blockade of neurotensin-induced motor activity by inhibition of protein kinase.

Authors:  P W Kalivas
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

Review 8.  An update on the connections of the ventral mesencephalic dopaminergic complex.

Authors:  L Yetnikoff; H N Lavezzi; R A Reichard; D S Zahm
Journal:  Neuroscience       Date:  2014-04-13       Impact factor: 3.590

Review 9.  Multiplexed neurochemical signaling by neurons of the ventral tegmental area.

Authors:  David J Barker; David H Root; Shiliang Zhang; Marisela Morales
Journal:  J Chem Neuroanat       Date:  2016-01-04       Impact factor: 3.052

10.  Autoradiographic localization of gamma-aminobutyric acidA receptors within the ventral tegmental area.

Authors:  L Churchill; R P Dilts; P W Kalivas
Journal:  Neurochem Res       Date:  1992-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.